Target intelligence / Profile preview

Host Cells and Extracellular Matrix Proteins

Molecular classification
Other, Structural proteins, Cellular components
01

Overview

Host Cells and Extracellular Matrix Proteins is a collective term describing the cellular and structural environment of biological tissues rather than a specific, individual molecular target. Host cells are the living cells of an organism that can be infected by pathogens or targeted by therapies, while the extracellular matrix (ECM) is a non-cellular three-dimensional network composed of macromolecules such as collagen, enzymes, and glycoproteins that provide structural support and regulate cell behavior (Source: NIH National Cancer Institute). In a therapeutic context, specific elements within this category are targeted; for example, integrins on host cells are targeted to prevent inflammation, and ECM-degrading enzymes are used to treat fibroproliferative disorders (Source: Nature Reviews Drug Discovery). Because the term encompasses a vast array of distinct proteins and cell types with diverse functions, it is generally classified as a broad biological compartment or site of action rather than a single druggable receptor or enzyme (Source: StatPearls). Drugs that interact with these components typically function by inhibiting cell-matrix adhesion, disrupting structural integrity to enhance drug penetration, or blocking receptors used by viruses for entry (Source: PubMed). This category is critical in understanding disease progression in cancer metastasis and chronic fibrosis, where the remodeling of the matrix plays a central role in pathology (Source: Journal of Cell Biology).

Other names
Extracellular matrixECMHost cell componentsCellular microenvironmentTissue matrix
02

Mechanism of action

Modulation of cell-matrix interactions, enzymatic degradation of structural matrix components, or competitive inhibition of host cell surface receptors used for adhesion and signaling.

03

Biological functions

Cell adhesionStructural supportSignal transductionTissue homeostasisPathogen entryMechanotransduction
04

Disease associations

CancerFibrosisInfectionInflammationWound healingMetastasis
05

Safety considerations

Impaired wound healingLoss of tissue structural integrityOff-target systemic toxicity due to ubiquityPotential for autoimmune reactionsIncreased risk of hemorrhage
06

Interacting drugs

Collagenase clostridium histolyticum

5 more in the full profile.

07

Biomarkers

Matrix metalloproteinases (MMPs)Type I collagen C-telopeptide (CTX)FibronectinLamininProcollagen type III N-terminal peptide (PIIINP)

Beyond the preview

Go deeper on Host Cells and Extracellular Matrix Proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host Cells and Extracellular Matrix Proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call